# A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

> **NCT07681089** · PHASE2 · RECRUITING · sponsor: **Kiminori Kimura, MD** · enrollment: 7 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Foscenvivint

## Key facts

- **NCT ID:** NCT07681089
- **Lead sponsor:** Kiminori Kimura, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-03-31
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2026-10-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681089, "A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*